Other

Natera, Inc.·Balance Sheet Statement·48 metrics

Breakdown

Loading...

Metrics

Cumulative Cost Basis

Line of Credit Remaining Borrowing Capacity

Accrued charges for third-party testing

Clinical trials and studies

Property and equipment purchases

Accrued Insurance Current And Noncurrent

Accrued Professional Fees Current And Noncurrent

Accrued shipping charges

Accrued third-party service fees

Testing and laboratory materials from suppliers

Allowance for doubtful accounts

Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax

Gross Unrealized Gains

Total

Available for sale investments

Business Combination, Contingent Consideration, Liability

Clinical samples payable

Common stock, par value (in dollars per share)

Common stock, shares authorized (in shares)

Common stock, shares issued (in shares)

Common Stock, Shares, Outstanding

Contract with Customer, Liability

Debt instrument, collateral amount

Debt Securities, Available-for-Sale, Allowance for Credit Loss

Deferred Tax and Other Liabilities, Noncurrent

2031 and thereafter

Finite-Lived Intangible Assets, Accumulated Amortization

2028

2030

Remainder of 2026

2027

2029

Gross Carrying Amount

Goodwill, Gross

Lessee Operating Lease Liability Payments Due

2031 and thereafter

Lessee Operating Lease Liability Undiscounted Excess Amount

Estimated litigation liability

Operating Lease Weighted Average Discount Rate Percent

Other accrued expenses

Purchase Obligation

Sales and income tax payable

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Penalties and interest accrued on unrecognized tax benefits

Purchase Obligation

Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2025